Pharma Focus Asia
KP - Sustainable Packaging Solutions

Pfizer Invests US$500 million For Gene Therapy Facility Expansion

Introduction:

Pfizer has announced its plans to invest US$500 million to construct a state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina.

Features:

The expansion is meant to help advance Pfizer's gene therapy line, specifically in manufacturing custom-made recombinant adeno-associated virus (rAAV) vectors.

The Sanford plant manufactures therapies used for the late-stage experimental treatments for Duchenne Muscular Dystrophy (DMD) and hemophilia B therapies, among other gene therapies.

The Sanford plant will also make components for some of the vaccines, such as Prevnar 13.

This new facility will also provide gene therapies to support both clinical development and eventual commercial development.

Specifications:

NamePfizer
LocationSanford, North Carolina
TypeExpansion
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024CPHI Chine || PMEC China 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024CPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?